Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry and neurology, today announced study ...

In an exploratory clinical trial, four male patients diagnosed with major depressive disorder underwent eight weeks of treatment with a device that generates a low-frequency ultralow magnetic field ...

New research suggests that psilocybin, a compound found in magic mushrooms, may be effective in treating depression symptoms.

Ketabon is working to develop a medication that harnesses ketamine’s antidepressant effects without the safety issues that ...

Voltaire’s famous aphorism of “doctors prescribing drugs of which they know little to patients of whom they know less” may ...

Findings are encouraging but further evidence is needed before any clinical recommendations can be made, say experts.

NRx Pharmaceuticals’ investigational antidepressant has failed to reach statistical significance in reducing depression ...

Scientists at the University of Oxford analysed the results of seven trials involving 436 participants with depression to ...

Psilocybin outperformed a variety of "control" treatments in easing symptoms of depression, researchers reported Wednesday in ...

‘Magic mushrooms’ can provide effective treatment for depression after one or two doses, a new study has found. A single dose ...

International scientists argue psilocybin could be used to treat depression on a larger scale but important questions remain unanswered.

Announcing a new publication for Acta Materia Medica journal. Agomelatine (AGO) is an antidepressant with limited clinical application due to its low bioavailability caused by poor water solubility, ...